Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3626473 | 1.00 | CTSD (0.32) | CTSDALDH1A1 | |
| SCHEMBL15658134 | 0.82 | — | — | |
| SCHEMBL16582527 | 0.79 | CTSD (0.39) | CTSD | |
| SCHEMBL3166077 | 0.76 | — | — | |
| SCHEMBL15659426 | 0.76 | — | — | |
| SCHEMBL2689498 | 0.74 | — | — | |
| SCHEMBL10589435 | 0.73 | TSHR (0.33) | — | |
| SCHEMBL13491264 | 0.71 | POLB (0.31) | — | |
| SCHEMBL3676231 | 0.71 | LMNA (0.43) | — | |
| SCHEMBL3682464 | 0.71 | LMNA (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630491-B2 | Production of 2,2,4,4-tetramethylcyclobutane-1,3-diol from secondary alcohols and 2,2,4,4-tetramethylcyclobutanedione using homogeneous catalysts | EASTMAN CHEMICAL COMPANY (US) | 2026-05-19 | — | — | US | claimed |
| US-12577184-B2 | Production of 2,2,4,4-tetramethylcyclobutane-1,3-diol from isobutanol using a homogeneous catalyst | EASTMAN CHEMICAL COMPANY (US) | 2026-03-17 | — | — | US | claimed |
| US-20250194617-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-06-19 | — | — | US | claimed |
| CN-120136688-A | Preparation method of 2, 4-tetramethyl-1, 3-cyclobutanedione | 青岛科技大学 | 2025-06-13 | — | — | CN | claimed |
| US-20250169514-A1 | Materials and Methods for Extending Shelf-Life of Foods | JP LABORATORIES, INC. | 2025-05-29 | — | — | US | claimed |
| EP-4543841-A2 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | The University of North Carolina at Chapel Hill (US) | 2025-04-30 | — | — | EP | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| EP-4255873-B1 | PRODUCTION OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1, 3-DIOL FROM ISOBUTANOL USING A HOMOGENEOUS CATALYST | EASTMAN CHEM CO (US) | 2024-12-18 | — | — | EP | claimed |
| EP-4255881-B1 | PRODUCTION OF 2,2,4, 4-TETRAMETHYLCYCLOBUTANE-1, 3-DIOL FROM SECONDARY ALCOHOLS AND 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIONE USING HOMOGENEOUS CATALYSTS | EASTMAN CHEM CO (US) | 2024-12-18 | — | — | EP | claimed |
| WO-2023250180-A2 | CATALYTIC CARBOXYCARBONYLATION OF ALKENES TO FORM ANHYDRIDES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-12-28 | — | — | WO | claimed |
| US-20080132742-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; cesium and cobalt promoters; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | EASTMAN CHEMICAL COMPANY (US) | 2008-06-05 | — | — | US | claimed |
| US-6797745-B1 | Hot melt inks containing styrene or terpene polymers | XEROX CORPORATION | 2004-09-28 | — | — | US | claimed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| EP-0681564-A1 | PROCESS FOR THE MANUFACTURE OF 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIOL | EASTMAN CHEMICAL COMPANY (US) | 1995-11-15 | — | — | EP | claimed |
| EP-0600019-B1 | PROCESS FOR THE MANUFACTURE OF 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIOL | EASTMAN CHEM CO (US) | 1995-10-18 | — | — | EP | claimed |
| WO-1994018146-A1 | PROCESS FOR THE MANUFACTURE OF 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIOL | EASTMAN CHEMICAL COMPANY (US) | 1994-08-18 | — | — | WO | claimed |
| EP-0600019-A1 | PROCESS FOR THE MANUFACTURE OF 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIOL. | EASTMAN KODAK CO (US) | 1994-06-08 | — | — | EP | claimed |
| US-5258556-A | DISSOLVING DIMETHYLKETENE FROM PYROLYZING ISOBUTYRIC ANHYDRIDE IN 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIONE, DIMERIZING DIMETHYLKETENE AND HYDROGENATING RESULTING 2,2,4,4-TETRA-METHYLCYCLOBUTANE-1,3-DIONE | EASTMAN KODAK COMPANY (US) | 1993-11-02 | — | — | US | claimed |
| WO-1993004026-A1 | PROCESS FOR THE MANUFACTURE OF 2,2,4,4-TETRAMETHYLCYCLOBUTANEDIOL | EASTMAN KODAK COMPANY (US) | 1993-03-04 | — | — | WO | claimed |
| US-5169994-A | Process for the manufacture of 2,2,4,4-tetramethycyclobutanediol | EASTMAN KODAK COMPANY (US) | 1992-12-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132742-A1 | by hydrogenation of a 2,2,4,4-tetraalkylcyclobutane-1,3-dione; cesium and cobalt promoters; specific cis/trans isomer ratio in order to control glass transition temperatures and/or crystallization rates in copolyesters | CA3, TELO2, CA1 | CTSD 1623/4885ALDH1A1 928/4885 |
| US-12630491-B2 | Production of 2,2,4,4-tetramethylcyclobutane-1,3-diol from secondary alcohols and 2,2,4,4-tetramethylcyclobutanedione using homogeneous catalysts | ADH1C, ADH1A, ADH5 | CTSD 4869/4885ALDH1A1 195/4885 |
| US-12577184-B2 | Production of 2,2,4,4-tetramethylcyclobutane-1,3-diol from isobutanol using a homogeneous catalyst | HAO2, TDO2, THRB | CTSD 3941/4885ALDH1A1 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.